Eiko N. Minakawa

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Gender Disparity in Movement Disorders Research Authorship: Progress and Persistent Gaps Across a Decade.

Gender Disparity in Movement Disorders Research Authorship: Progress and Persistent Gaps Across a Decade.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: June 02, 2026

MDS Global Survey on Work Environment, Career Advancement, and Work-Life Balance in Movement Disorders Professionals: Gender and Regional Patterns.

MDS Global Survey on Work Environment, Career Advancement, and Work-Life Balance in Movement Disorders Professionals: Gender and Regional Patterns.

Journal: Movement disorders clinical practice

Published: November 19, 2025

Blood extracellular vesicles contribute to the exercise-mediated suppression of brain Aβ pathology in the AppNL-G-F knockin mouse model of Alzheimer's disease.

Blood extracellular vesicles contribute to the exercise-mediated suppression of brain Aβ pathology in the AppNL-G-F knockin mouse model of Alzheimer's disease.

Journal: Neurochemistry international

Published: November 18, 2025

Oral administration of arginine suppresses Aβ pathology in animal models of Alzheimer's disease.

Oral administration of arginine suppresses Aβ pathology in animal models of Alzheimer's disease.

Journal: Neurochemistry international

Published: September 22, 2025

Establishment of a second-generation transgenic marmoset with germline transmission that models polyglutamine disease.

Establishment of a second-generation transgenic marmoset with germline transmission that models polyglutamine disease.

Journal: Disease models & mechanisms

Published: May 07, 2025

Synthesis of 18F-Labeled FC-119S and Its Tosyl Precursor.

Synthesis of 18F-Labeled FC-119S and Its Tosyl Precursor.

Journal: Journal of labelled compounds & radiopharmaceuticals

Published: January 28, 2025

L-arginine in patients with spinocerebellar ataxia type 6: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

L-arginine in patients with spinocerebellar ataxia type 6: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

Journal: EClinicalMedicine

Published: May 26, 2024

Dysregulation of stress granule dynamics by DCTN1 deficiency exacerbates TDP-43 pathology in Drosophila models of ALS/FTD.

Dysregulation of stress granule dynamics by DCTN1 deficiency exacerbates TDP-43 pathology in Drosophila models of ALS/FTD.

Journal: Acta neuropathologica communications

Published: September 01, 2023

Optimization of piggyBac transposon-mediated gene transfer method in common marmoset embryos.

Optimization of piggyBac transposon-mediated gene transfer method in common marmoset embryos.

Journal: PloS one

Published: December 26, 2022

Bidirectional Relationship Between Sleep Disturbances and Parkinson's Disease.

Bidirectional Relationship Between Sleep Disturbances and Parkinson's Disease.

Journal: Frontiers in neurology

Published: April 25, 2022

Sustained therapeutic benefits by transient reduction of TDP-43 using ENA-modified antisense oligonucleotides in ALS/FTD mice.

Sustained therapeutic benefits by transient reduction of TDP-43 using ENA-modified antisense oligonucleotides in ALS/FTD mice.

Journal: Molecular therapy. Nucleic acids

Published: April 22, 2022

Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases.

Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases.

Journal: Frontiers in neuroscience

Published: October 27, 2020

Showing 1-12 of 24

Last Updated: 09/26/2026